Result of SGM and Notification of change to Shares

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

Cathay International Holdings Limited

("Cathay" or the "Company")

Results of Special General Meeting ("SGM") and

Notification of intended cancellation of Common Shares from the Official List and of trading on the Main Market of the London Stock Exchange

Hong Kong, 3 November 2020 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today announces that at the SGM held earlier today, the Resolutions as set out in the Notice of Special General Meeting dated 16 October 2020 were duly passed.

Final Poll Voting Result

The final poll voting results for the Resolutions are shown in the table below.

Notes:

1. A copy of the Resolutions passed at the meeting is being uploaded today to the National Storage Mechanism and will shortly be available for viewing at www.morningstar.com.

2. The final voting result for the Resolutions will also be displayed on the Company website at www.cathay-intl.com.hk

3. In accordance with the voting structure set out in the SGM circular dated 16 October 2020, Resolution 1 requires the Company to obtain: (i) at least a simple majority of more than 50 per cent. of the total number of votes cast for and against the Listing Cancellation Resolution by the Common Shareholders, excluding the Controlling Shareholders; (ii) at least a majority of not less than 75 per cent. of the total number of votes cast for and against the Listing Cancellation Resolution by the Common Shareholders; and (iii) at least a majority of not less than 75 per cent. of the total number of votes cast for and against the Listing Cancellation Resolution by the Common Shareholders and the A Shareholders voting together.

4. Any proxy votes which are at the discretion of the Chairman have been included in the 'For' total.

5. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the Resolutions.

Notice of Intended Cancellation of Listing of the Company's Shares

Pursuant to the Listing Rules, the Company is required to give at least 20 business days' notice of its intended Listing Cancellation. The Company will today apply to the Financial Conduct Authority to cancel the listing of the Company's common shares (the "Shares") on the standard segment of the Official List and trading on the Main Market of the London Stock Exchange (the "Listing Cancellation"). It is anticipated that the effective date of the Listing Cancellation will be at 8:00 am (London time) on 2 December 2020.

Tender offer

As a reminder, the latest time and date for receipt of Tender Forms and TTE Instructions in relation to the Tender Offer, details as set out in the Tender Offer Circular dated 16 October 2020, will be at 11:00 a.m. (London time) on 10 November 2020.

The Company expect to announce the results of Tender offer on 11 November 2020.

- ENDS -

For further enquiries, please contact:

About Cathay 

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 1,300 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.